Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: sam who wrote (5184)	8/19/1998 2:39:00 PM
From: aknahow	Read Replies (1) of 6136

With the recent merger news/rumors for European drug industry and DuPont situation I think it is logical that any bioteck with sales and at least prospective earnings can be considered a target. Disclosure, have written Aug 25 puts on AGPH. Unless todays rise is reversed the stock will not be put to me. Months ago JJC at TSC wrote about the importance of not ignoring brokerage house up/down "grades". Even though we all know they usually have a relationship with the company changes have a big impact in the short term. So while I think AGPH is at least being considered as a target I would not eliminate the probability that the spurt is due only to the upgrade. From this post it should be clear, I don't know why it moved up either!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next